It’s that time of the year again. Open enrollment for insurance has closed, and it is time to start using your new 2018 plans. Sometimes, understanding your health coverage and planning for your healthcare needs can be challenging.

Following a recent review of Tussionex^® (hydrocodone polistirex and chlorpheniramine polistirex) – a cough syrup containing hydrocodone and chlorpheniramine– we determined the benefit-risk balance for the use of Tussionex^® to treat cough associated with cold or allergy in children was no longer favorable. Because of this, UCB proactively approached the U.S. Food and Drug Administration (FDA) to request that Tussionex^® be limited to use in adults.